BIM
ADVM

BlackRock Investment Management’s Adverum Biotechnologies ADVM Stock Holding History

BlackRock Investment Management’s Portfolio ADVM Stock Details ADVM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$318K Hold
10,960
– – ﹤0.01% 3153
2016
Q3 		$450K Buy
10,960
+1,774
+19% +$67.3K ﹤0.01% 3085
2016
Q2 		$290K Buy
9,186
+2,271
+33% +$103K ﹤0.01% 3228
2016
Q1 		$358K Buy
6,915
+124
+2% +$6.92K ﹤0.01% 3020
2015
Q4 		$646K Buy
6,791
+14
+0.2% +$1.23K ﹤0.01% 2885
2015
Q3 		$558K Sell
6,777
-158
-2% -$20.2K ﹤0.01% 2983
2015
Q2 		$1.13M Buy
6,935
+4,665
+206% +$1.57M ﹤0.01% 2677
2015
Q1 		$920K Sell
2,270
-89
-4% -$37.6K ﹤0.01% 2579
2014
Q4 		$1.27M Buy
2,359
+62
+3% +$23.9K ﹤0.01% 2378
2014
Q3 		$785K Buy
+2,297
New +$683K ﹤0.01% 2678

Other funds holding ADVM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

BlackRock Investment Management's ADVM Position: Q4 2016 in Review

BlackRock Investment Management held its Adverum Biotechnologies (ADVM) position steady in Q4 2016 at 10,960 shares worth $318K. The position accounts for ﹤0.01% of the portfolio, ranked #3153.

BlackRock Investment Management first reported a position in ADVM in Q3 2014 and has held it in 10 quarters since. The position peaked at $1.27M in Q4 2014. 83 funds tracked by Wall St. Rank hold ADVM as of Q4 2016.

  • BlackRock Investment Management held 10,960 shares of Adverum Biotechnologies worth $318K as of Q4 2016.
  • BlackRock Investment Management left its Adverum Biotechnologies share count unchanged in Q4 2016.
  • Adverum Biotechnologies made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3153 holding.
  • BlackRock Investment Management first reported a position in Adverum Biotechnologies in Q3 2014 and has held it in 10 quarters since.
  • BlackRock Investment Management's Adverum Biotechnologies position peaked at $1.27M in Q4 2014.
  • 83 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.